In 2025, the beauty industry stands at the threshold of a profound transformation, driven by digitalisation, hyper-connectivity, and an unprecedented demand for evidence-based, personalised skin care.
Today’s consumers are not only inclusive and environmentally conscious but also data-savvy, seeking products tailored to their unique biological profiles, lifestyles, and environmental exposures.
Building on early personalisation initiatives in the 2000s and bespoke shade adaptation in the 2010s, the field now leverages artificial intelligence, advanced data analytics, and miniaturised sensing technologies to deliver unprecedented precision in cosmetic care.
Central to this evolution is the integration of skin biomarkers, molecular, proteomic, lipidomic, and biophysical indicators, that provide mechanistic insight into hydration, barrier function, inflammation, oxidative stress, and microbiota composition.
Historically assessed on isolated epidermal or dermal cells or reconstructed skin models, these markers can now be measured via advanced, non-invasive sampling methods, including swabbing and tape-stripping.
When combined with high-throughput omics analyses, these approaches bridge laboratory-grade precision with real-world, consumer-accessible applications.
This article explores the current landscape and future potential of biomarker-based diagnostics in dermocosmetics.
The future of beauty science lies in harmonising miniaturised, high-resolution analytics withconsumer-centered usability
By examining technological, analytical, and methodological innovations, we highlight how connected, portable, and high- resolution tools are poised to redefine personalised beauty, transforming skin assessment from descriptive observation into a predictive and actionable science.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.